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| K E Y ELEMENTS IN T YPE 2 IMMUNE RE SP ONSE S
Dendritic cells (DCs) are an innate immune population absolutely required for the development of optimal effector Th cell immune responses, including Th2 responses. 4, 5 DCs are intimately associated with barrier sites such as the lungs and will take up antigens from within and beyond the epithelial barrier. Upon detection of a helminth infection or an environmental allergen, 6 DCs become activated and migrate to the draining lymph nodes, presenting antigens to T cells and potentially inducing a Th2 immune response.
Although the critical involvement of DCs in Th2 development is
clear, the precise signals that lead to priming of a Th2-inducing DC are incompletely characterized. In recent years, the importance of epithelial-derived cytokines such as interleukin-25 (IL-25), IL-33 and thymic stromal lymphopoietin (TSLP) in allergy and parasitic infection has become appreciated. 7 These cytokines can act directly on DCs, skewing resultant responses to Th2, and also directly activate type 2 innate lymphoid cells (ILC2s), inducing a rapid innate type 2 response.
ILC2s are innate lymphocytes, lacking antigen-specific receptors, which produce large amounts of type 2 cytokines IL-5, IL-13 and IL-9, as well as proresolving factors amphiregulin 8 and IL-10. 9 Activated
ILC2s also express class II MHC, can present peptide antigen and can supply IL-4R signals in type 2 response initiation. 
| HELMINTH INFEC TI ON S , DAMAG E AND T YPE IMMUNE RE S P ON S E S

| TALE S OF WORMS IN MEN
In the 1970s, the "hygiene hypothesis" was proposed as an explanation for the steep and alarming rise in the prevalence of childhood allergies and asthma among urban, Westernized societies. The hygiene hypothesis links changes in housing, sanitation and health care to increased allergic disease and proposes that this is in part due to reduced endemic infections. The prevalence of parasitic infections in particular has been drastically reduced in Westernized societies over the last century and is therefore proposed to be an important contributing factor in this hypothesis. Multiple epidemiological studies have been used to support this hypothesis by indicating that in helminth-endemic rural areas relatively few people have allergic symptoms. 30, 31 The fact that some local African languages contain no words to describe allergic symptoms could support this hypothesis, indicating that allergic diseases have never been a problem among these populations. 32 However, an examination of the many population studies of the past 30 years either by meta-analyses 33, 34 or in some excellent systematic reviews 35, 36 shows that the direction of the effect by helminth infections is far from consistent. 33 Greater consensus was observed regarding protection to atopic sensitization and allergic skin reactivity, although the outcome varied with the allergen studied. [34] [35] [36] Similarly, studies using anthelmintic treatment of helminthendemic populations show mixed results (for a full overview, see Wammes, 2014 35 )-some show an increased frequency of allergen skin prick test (SPT) after worm clearance, 37 while others did not observe any differences between treatment and control groups within one or 2 year time frames. 38 Part of the inconsistent findings and dissimilarities in conclusion in the epidemiological and interventional studies may be explained by variations in factors such as the age of the population studied, age of helminth exposure (and consequent early-life immune imprinting) and the infectious burden, endemic parasite species and chronicity of infection, or differences in study parameters such as clinical symptoms in asthma, rhinitis or eczema or methods used to measure allergen sensitization (SPT versus allergen-specific IgE). 35, 39 Epidemiological studies applying antihelminthic treatment during pregnancy provide an interesting approach to evaluate the relationship between helminths, early immune priming and allergy: these show an increased risk of early-life eczema in babies of treated mothers 37, 40 ; however, a 9-year follow-up showed that this effect was not maintained to later life. 41 In contrast to human studies, experiments in mice showed more consistent findings in the prevention of allergic airway inflammation by a wide range of helminth species: N. brasiliensis, 42 Heligmosomoides polygyrus, 43 Litomosoides sigmodontis, 44 Schistosoma mansoni, 45 Trichinella spiralis 46 and Schistosoma japonicum. 47, 48 Interestingly, transmaternal protection against allergic airway inflammation by helminth infection in mice implied that this was dependent on the phase of the infection during pregnancy:
offspring from schistosome-infected females were protected if they had mated during the initial Th1 phase, or the chronic immuneregulatory phases of schistosome infection, but conversely disease was exacerbated if mating occurred during the high Th2 phase of infection (coinciding with egg deposition). 49 This may further complicate assessment of human population studies, as protection against allergy may depend on far more complicated interactions than simple presence of infection, but also prenatal stimuli and phase of infection. Helminths not only change the response to other infectious agents within the host but can also affect the balance of commensal organisms with which they share an environment. The host genome and the total diversity of the microbiota (the "microbiome") are important in mediating or reflecting health and disease in the intestine, and in other barrier sites such as the lung and skin. Changes in the gut and lung microbiomes are seen in allergic diseases such as asthma, 60 reflecting the immune axis between these mucosal sites or transfer of bacterial populations through processes such as inhalation of airborne bacteria, bacterial migration along mucosal surfaces and microaspiration of gastric contents. 61 Although many studies of the microbiome focus on faecal contents, it is important to note that intestinal helminths infect specific niches within the intestine: that is Trichuris spp in the large intestines, and human hookworms, H. polygyrus and N. brasilienesis in the small intestines. In humans living in helminth-endemic areas and during experimental helminth infection, helminth infection is associated with increased diversity and abundance of the microbiome. [62] [63] [64] [65] Although it has not been demonstrated whether these differences are related to differences in lifestyle and hygiene or causally linked to current helminth infection, the fact that changes in the microbiota are partially abrogated on anthelmintic treatment supports the latter hypothesis. 63 In several mouse models, intestinal helminth infections induced a decreased prevalence of commensals associated with inflammation 66, 67 and increase in commensals associated with immune regulation. 63, 68 This is proposed to be an active process, mediated by secreted antimicrobials from the parasite (such as host defence peptides), 69 or mediated by (type 2) immune responses directed against or modulated by the parasite. 63, 70 Consequently, changes in the microbiota (due to, eg changes in diet) and microbial metabolite levels (such as short-chain fatty acids) mediate changes in allergic responsiveness. 71 Interestingly, a recent study also found altered fatty acid production by the microbiota of H. polygyrus-infected mice and their additional role in protection against allergic airway inflammation. 72 
| HELMINTH INTER AC TI ON S WITH OTHER INFEC TI ON S AND THE MI CROB I OTA
| RE WORMING THE WE S T
The growing support for the idea that helminth infections suppress inflammatory responses led to the proposal of using helminth infections as therapeutic agents in these diseases. In the first clinical trials of "helminth therapy," patients with inflammatory bowel dis- [83] [84] [85] Of most relevance to this review, studies using hookworm infection to treat asthma or TSO to treat allergic rhinitis patients have also been undertaken. However, no change in clinical measurements was seen in either study, 86 and although type 2 specific responses were detected against the hookworm, no regulatory immune responses were found. 87 Thereby, the promise of helminth therapy has so far not translated to a practicable treatment for human disease. Reasons for this may well include difference between prevention and cure (ie parasitic infection may need to precede allergic sensitization, and effect could be in utero 49 ), the difference between infection and administration of parasite products (most of the therapeutic effects in mouse models were based on the application of helminth products rather than a full infection), the single parasite infective dose given (which is generally determined by that which causes no notable side effects, but may therefore be too low and too little for functional suppression of pathology) or disease endotypes which are responsive or refractory to these treatments, precluding statistical significance of effects when the disease population is taken as a whole. 88 Critically, however, the mechanism of action of helminth immunomodulation is not well understood, and whether this is shared between all helminth infections, or more likely unique to each parasitic species, is presently unknown (Figure 1 ).
F I G U R E 2
Immune responses during helminth infections. Depending on their life cycle, various helminth species will pass or reside in (the proximity of) the lung and the gut. Consequently, damage will occur, leading to the release of alarmin cytokines IL-33, IL-25 and thymic stromal lymphopoietin (TSLP) by epithelial cells and tuft cells (gut). These cytokines will act on innate lymphoid cells (ILC)2 and on dendritic cells (DCs), which will migrate to the draining lymph node and skew naïve T cells towards polarized Th2 cells, producing the cytokines IL-4, IL-5 and IL-13, in a similar fashion as ILC2s. These cytokines are central to the type 2 immune response and drive the isotype switch to IgE immunoglobulins, act on eosinophils, mast cells and drive the development of alternatively activated macrophages. All these elements are instrumental in worm expulsion but can also promote tissue damage, anaphylaxis and allergic responses towards bystander antigens. These responses are balanced by various cells from the regulatory network: for example regulatory T and B cells, regulatory macrophages and tolerogenic DCs. These regulatory cells can act on other cell types directly or through the production of anti-inflammatory cytokines IL-10 and TGF-β, as well as by the induction of anti-inflammatory IgG4, leading to immune tolerance and damage control, but at the same time prevent worm expulsion, promoting chronic helminth infections. Image is adapted from Servier Medical ART In the following sections, we will focus on mechanisms by which type 2 immune responses are suppressed or induced in helminth infections, and how this could affect allergic responses (Figure 2 for a schematic overview). A deeper understanding of the interaction between helminths and their host will help to translate these mechanisms into a better therapeutic approach. 100 Thus, in this context, its main function appears to be a blocking one, and possibly instrumental in preventing IgE-mediated inflammation. High levels of anti-Ascaris IgG4 have been negatively associated with allergen SPT positivity, 102 while in a S. mansoniendemic area-although higher levels of both IgE and IgG4 were found in infected individuals-a higher ratio of IgE to IgG4 predicted clinical allergic symptoms, 103 just as in allergen-specific immunotherapy. 104 As many helminth products are homologous to common allergens, IgG4 responses raised against helminth products may also bind and block IgE epitopes on allergens, reducing responses to allergens and directly reducing SPT responses. [105] [106] [107] Mechanistic research into the role of IgE and/or IgG4 is hampered by the lack of good experimental animal models, as IgG4 does not exist in mice. identified in an unbiased approach across tissues and species 137, 138 .
| HELMINTH S AND MODUL ATI ON OF ALLERG I C D IS E A S E: THE ROLE OF IMMUNOG LOBULINS , REG UL ATORY CELL S AND C Y TOK INE INHIB ITOR S
| Immunoglobulins
| Regulatory cells
While cDC1 can produce high levels of IL-12p70 and prime cytotoxic CD8 T-cell and antitumour responses, cDC2 can boost both Th17 or Th2 cells depending on the environment and show superior allergen uptake compared to cDC1. [139] [140] [141] [142] [143] [144] Interestingly, cDC1 can also have a tolerogenic function in allergy models: they induce Treg cells via retinoic acid and peroxisome proliferator-activated receptor gamma (PPARγ) and limit inflammation in a HDM and ovalbumin model of allergic airway inflammation 145 and during schistosome infections. 146 In patients with asthma, increased numbers of DCs are found in the blood, induced sputum and bronchoalveolar lavage upon allergen challenge, but only cDC2 migrated into the bronchial tissue. 147 The DCs express more OX-40L, a molecule involved in Th2 polarization 148 and more FcεRI. 149 In the absence of DCs, type 2 responses in allergy models are profoundly abrogated, 150 but other myeloid cell populations may also be important to support Th2 cell development in either allergy models or helminth infection, like monocyte-derived dendritic cells.
140,141
Macrophages differentiate into alternatively activated or M2 macrophages in response to IL-4 and IL-13. 160 and asthma 161 by a mechanism dependent on Treg expansion. Although the full mechanism of action of these molecules has yet to be elucidated, it appears that they achieve Treg expansion through modulation of dendritic cell responses. 
172-175
Other molecules that act on dendritic cell/macrophage function and dampen experimental allergic airway inflammation are identified from Clonorchis sinensis, A. caninum, A. viteae, Brugia malayi and Anisakis simplex. 161, 166, 167, [176] [177] [178] Further studies are needed to clarify whether these molecules can also be used in allergic and asthmatic patients in a therapeutic setting without the disadvantages of the infection itself.
| Innate lymphoid and epithelial cells
The importance of early, innate, epithelial cell-derived cytokines in type 2 response initiation has only recently begun to be understood.
The epithelial cell cytokines IL-25, IL-33 and TSLP activate ILC2s at barrier sites, which secrete large amounts of IL-5, IL-13 and IL-9.
Recently, it was shown that ILC2s can also be activated to produce IL-10, providing a immunoregulatory pathway (similar to that seen in T cells) which could be amenable to parasite immunomodulation. Recently, it was shown that cholinergic neurons activate [182] [183] [184] and adrenergic neurons inhibit 185 ILC2 responses, while type 2 cytokines in turn activate neurons, 186 forming a new field of neuroimmune interactions for future studies, and potential helminth modulation.
| CON CLUDING REMARK S
Helminth parasites have coevolved with their mammalian hosts for millions of years, and in doing so have developed an intimate relationship. On the one hand, this relationship can be seen as antagonistic, with the parasite attempting to subvert immune responses to its own ends, while the host immune system attempts to damage or kill the parasite. Alternatively, it can be seen as a mutualistic interaction, with parasite immunomodulation expected by the host immune system, and in fact required for healthy immune development, and avoidance of immune-mediated disease. It is likely that both forms of interaction occur, depending on context, parasite and environment. "Gene-environment" interactions in allergy and helminth infections are further complicated by "infection- 
